Ottawa biotech startup gets US$1M boost in quest to find treatment for muscle-wasting disease
Scientists at Satellos Bioscience are working on a drug that will help regenerate muscle tissue in patients who suffer from Duchenne muscular dystrophy.
Skip to content
Parent Project Muscular Dystrophy
Get our email updates
Get up-to-date news about the companies, people and issues that impact businesses in Ottawa and beyond.
The Latest
Video
OBJ360
Sponsored
Sponsored
Campaign to Create Tomorrow
Learn more about The Ottawa Hospital's $500-million fundraising campaign, the largest in our city’s history, which will transform the future of healthcare in Ottawa.
EXPERT BLOGS
EVENTS
OBJ news delivered to your inbox
Get up-to-date news about the companies, people and issues that impact businesses in Ottawa and beyond.